Operating Lease, Right-of-Use Asset of Prelude Therapeutics Inc from 31 Mar 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Prelude Therapeutics Inc quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2021 to 30 Sep 2025.
  • Prelude Therapeutics Inc Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $27,549,000, a 5.6% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Prelude Therapeutics Inc Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $27,549,000 -$1,633,000 -5.6% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $27,932,000 -$1,642,000 -5.6% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $28,315,000 -$1,792,000 -6% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $28,699,000 -$1,713,000 -5.6% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 $29,182,000 +$28,718,000 +6189% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $29,574,000 +$28,656,000 +3122% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $30,107,000 +$28,747,000 +2114% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $30,412,000 +$28,620,000 +1597% 31 Dec 2023 10-K 10 Mar 2025 2024 FY
Q3 2023 $464,000 -$890,000 -66% 30 Sep 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 $918,000 -$875,000 -49% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q1
Q1 2023 $1,360,000 -$864,000 -39% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $1,792,000 +$85,000 +5% 31 Dec 2022 10-K 15 Feb 2024 2023 FY
Q3 2022 $1,354,000 -$753,000 -36% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $1,793,000 -$104,000 -5.5% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $2,224,000 +$38,000 +1.7% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $1,707,000 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q3 2021 $2,107,000 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $1,897,000 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $2,186,000 31 Mar 2021 10-Q 11 May 2021 2021 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.